In contrast, patients with astrocytomas who had recently experienced seizures had significantly higher levels of IDH1 mutations than those who did not have seizures (6/14 vs. 2/20; p = 0.04). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).